Dr. Kaiser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
- Bascom Palmer Eye InstituteFellowship, 1996 - 1997
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1993 - 1996
- Massachusetts Eye and Ear InfirmaryClinical, Ophthalmology, 1993 - 1996
- Massachusetts General HospitalInternship, Internal Medicine, 1992 - 1993
- Harvard Medical SchoolClass of 1992
- Harvard CollegeBachelor of Arts, 1984 - 1988
Certifications & Licensure
- FL State Medical License 2004 - 2026
- IL State Medical License 2002 - 2026
- MA State Medical License 2002 - 2026
- MI State Medical License 2002 - 2026
- OH State Medical License 1997 - 2026
- PA State Medical License 2002 - 2026
- CA State Medical License 2002 - 2025
- American Board of Ophthalmology Ophthalmology
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Lew R. Wasserman Merit Award Research to Prevent Blindness 2010
- American Academy of Ophthalmology Senior Achievement Award (Senior Honor Award) 2008
- Join now to see all
Clinical Trials
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy Start of enrollment: 2006 Jul 01
- Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD Start of enrollment: 2007 Jul 01
- Optical Coherence Tomography in Multiple Sclerosis Patients Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials.Marko M Popovic, Michael Balas, SriniVas R Sadda, David Sarraf, Ryan Huang
Ophthalmology. 2024-12-01 - Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with t...Ashish Sharma, Peter K Kaiser, Ramin Tadayoni, Frank G Holz, Luke Nicholson
Eye. 2024-12-01 - Visual Loss in Geographic Atrophy: Learnings From the Lampalizumab Trials.Neha Anegondi, Verena Steffen, Srinivas R Sadda, Steffen Schmitz-Valckenberg, Adnan Tufail
Ophthalmology. 2024-11-22
Journal Articles
- HIV-1 coat protein increases intracellular Ca2+ and injures neurons: toxicity prevented by calcium channel antagonists.Dreyer EB, Kaiser PK, Offermann JT, and Lipton SA., Science 1990
- Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies.Kaiser PK, Offermann JT, and Lipton SA., Neurology 1990
- VIP-mediated increase in cAMP prevents TTX-induced retinal ganglion cell death in vitro.Kaiser PK and Lipton SA., Neuron 1990
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A study of the effects of vasoactive intestinal peptide on natural cell death of retinal ganglion cells.Kaiser PK, Summa cum laude honors thesis; Harvard College
- Vasoactive intestinal peptide via cAMP rescues mammalian retinal ganglion cells from tetrodotoxin-induced death.Kaiser PK and Lipton SA, Society for Neuroscience
- Calcium channel antagonists partially prevent neuronal cell killing by HIV-1 coat protein gp120 in vitro.Campo R, Offermann JT, Arroyo JG, Kaiser PK, Chen HS V, and Lipton SA, Society for Neuroscience
- Join now to see all
Lectures
- New treatment strategies for corneal abrasions.New England Ophthalmological Society Meeting, Boston, MA
- Digital Journal of Ophthalmology and other world wide web resources for ophthalmologists.American Academy of Ophthalmology Annual Meeting
- Submacular Surgery Trials.Cleveland Ophthalmology Society Meeting
- Join now to see all
Press Mentions
- Extended Dosing Intervals Possible with Aflibercept in Diabetic Macular EdemaNovember 18th, 2024
- New Framework for Deciding When to Operate on Patients with Epiretinal MembranesNovember 11th, 2024
- Cimerli Approved as Interchangeable Biosimilar to LucentisAugust 3rd, 2022
- Join now to see all
Grant Support
- Vacsular Remodeling And Effects Of Angiogenic Inhibition In Diabetic RetinopathyNational Eye Institute2006
- Vascular Remodeling And Effects Of Angiogenic InhibitionNational Eye Institute2005
Professional Memberships
- Fellow
- Member
- Macula SocietyMember
- Retina SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: